OUR LATEST NEWS
faceLITE Achieves Groundbreaking FDA Clearance for Non-UV LED Therapy in Treating Hand Dermatitis
faceLITE is proud to announce that its handLITE™ device has received FDA clearance (K250224), becoming the world’s first non-UV light therapy device approved for the treatment of irritant contact dermatitis (ICD) of the hand. This marks a significant breakthrough for the faceLITE brand and further reinforces our position as a leader in LED-based skincare and wellness innovation. It follows the recent FDA clearance of our décolletage wrinkle treatment device, underlining our ongoing commitment to creating safe, effective, and clinically proven light-based therapies for real-world conditions. Hand dermatitis remains a widespread and challenging issue, affecting hundreds of millions of people globally...
faceLITE’s handLITE™ has become the world’s first non-UV LED device FDA-cleared for the treatment of hand dermatitis. Backed by clinical data and developed by our parent company, iSMART, this breakthrough...
Read More
faceLITE Reveals the Science Behind LED Masks and What Really Matters
The LED mask market is booming - but how do you separate the marketing noise from truly skin-transforming technology? According to Sue D’Arcy, CEO of iSMART (the parent company behind faceLITE and a leading global manufacturer of LED phototherapeutic devices), it all comes down to three vital factors: Wavelength, Intensity, and Dose. Get just one of these wrong, and your LED mask might not work, or worse, could even be unsafe. Wavelength Different wavelengths penetrate the skin to different depths, targeting specific cells and chromophores (the parts of molecules that absorb light). If the wavelength is incorrect, the light won't...
Not all LED masks are created equal. faceLITE’s parent company iSMART reveals the three essential elements that make light therapy both safe and effective: wavelength, intensity and dose. Discover how...
Read More
faceLITE’s décoLITE Receives FDA Clearance for Décolletage Wrinkle Treatment
A major milestone in the world of aesthetic skincare faceLITE’s décoLITE device has received FDA clearance, becoming the first clinically proven, non-invasive LED solution for targeting wrinkles and pigmentation on the décolletage – an area often overlooked in traditional skincare routines. Developed by faceLITE’s parent company iSMART, décoLITE uses red and near-infrared light to stimulate the skin’s natural regeneration processes through photobiomodulation. In a six-week clinical trial, 84% of participants reported visible improvements in skin texture, pigmentation, and wrinkle depth. This FDA clearance cements iSMART’s position as a global leader in light-based anti-ageing innovation. With its flexible, wearable design, décoLITE delivers...
faceLITE’s décoLITE device is now FDA-cleared to treat wrinkles and pigmentation on the décolletage. Clinically proven and developed by parent company iSMART, this wearable LED solution delivers visible results in...
Read More
